I
| IDH1 Mutation |
| IDH2 Mutation |
| IGH /MAF/WWOX t(14;16)(14q32, 16q23) for Multiple Myeloma prognosis |
| IgH gene rearrangement ( Clonality Assay) |
| IgH gene rearrangement ( MRD Assay as Prognostic Marker ) |
| IgH Gene rearrangement for NHL |
| IGH/MAFB t(14;20)(14q32,20q12) for Multiple Myeloma prognosis |
| IgHV gene mutation – VH 3 &VH 4 ( CLL prognosis) (Sequencing) |
| IgHV gene mutation – VH1&VH2 ( CLL prognosis) (Sequencing) |
| IgHV gene mutation – VH5 & VH6 ( CLL prognosis) (Sequencing) |
| IGK Breakapart for Burkitt Lymphoma / ALL- L3 |
| Igk gene rearrangement ( Clonality Assay) |
| IgK gene rearrangement for NHL |
| IGL Breakapart for Burkitt Lymphoma / ALL- L3 |
| Influenza A |
| Influenza B |
| Influenza H3N2 |
| Influenza Virous H1N1 |
| Inv(16) or t(16;16);CBFB-MYH11 or CBFB-MYH11/ Inv16 |